Bausch Health
BHC
#4125
Rank
NZ$3.51 B
Marketcap
$9.52
Share price
-6.00%
Change (1 day)
-43.01%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2023 (TTM): -$4.29

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -$4.75. In 2022 the company made an earnings per share (EPS) of -$1.11 an increase over its 2021 EPS that were of -$4.75.

EPS history for Bausch Health from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.29286.5%
2022-$1.11-76.64%
2021-$4.7568.45%
2020-$2.82-68.91%
2019-$9.07-57.11%
2018-$21.14-272.22%
2017$12.28-199.29%
2016-$12.36798.7%
2015-$1.38-128.31%
2014$4.86-204.62%
2013-$4.65602.7%
2012-$0.66-171.15%
2011$0.93-143.96%
2010-$2.11-206.57%
2009$1.98-11.2%
2008$2.232.46%
2007$2.18-7.58%
2006$2.36-14.29%
2005$2.7554%
2004$1.79-500%
2003-$0.45-141.67%
2002$1.07-4.76%
2001$1.13-175%
2000-$1.50-268%
1999$0.8914.94%
1998$0.7820.83%
1997$0.6453.83%
1996$0.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.79-62.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.48-89.84%๐Ÿ‡บ๐Ÿ‡ธ USA